Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07127835

Provocation After Nurse-Directed Assessment (PANDA) Study

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
440 (estimated)
Sponsor
The University of Hong Kong · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study aims to evaluate the effectiveness and safety of a collaborative nurse-allergist approach in penicillin allergy delabeling services. It also seeks to assess the impact on patients' quality of life and compare resource utilization and cost-effectiveness between the nurse-allergist collaborative approach and the traditional allergist-led approach.

Detailed description

This study hypothesizes that by involving both nurses and allergists in the delabeling process and categorizing patients based on risk levels, it will achieve comparable success rates, safety, and improvements in patients' quality of life. This approach is expected to offer superior advantages in terms of time efficiency, resource utilization, and cost-effectiveness compared to traditional allergist-led services.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTNurse-led penicillin allergy delabelling servicePatients in this group undergo risk assessment and categorization by nurses to identify low-risk individuals for delabeling. For these patients, nurses will collaborate with allergists in the delabeling process.
DIAGNOSTIC_TESTAllergist-led penicillin allergy delabelling servicePatients assigned to this group will undergo risk assessment and delabeling led by allergists for both low-risk and high-risk cases.

Timeline

Start date
2025-09-01
Primary completion
2027-08-31
Completion
2029-08-31
First posted
2025-08-17
Last updated
2025-10-01

Locations

4 sites across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT07127835. Inclusion in this directory is not an endorsement.